ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

Sokoto J. Vet. Sci.. 2025; 23(1): 65-69


Management of canine transmissible venereal tumour in a four-year-old Nigerian indigenous dog

K Ibrahim, MN Bappah, S Muhammad, AA Bada, AA Bello, A Saleh, KA Mada, MJ Salihu, SA Muhammad & MD Bashir.



Abstract
Download PDF Post

Canine transmissible venereal tumour (TVT) is a contagious cancer with a global distribution, posing significant challenges in veterinary oncology. A Nigerian indigenous breed of dog was presented with the complaint of blood dripping and tissue growth from the preputial area. A blood sample and a biopsy of the cauliflower-like tissue growth were collected from the patient and analysed for complete blood count and histopathological examination, respectively. Canine TVT was tentatively diagnosed and subsequently confirmed through histopathology. Chemotherapy was initiated using Vincristine sulfate (0.025mg/kg intravenously) once per week for four weeks, resulting in a positive outcome. The client was advised not to use the dog for breeding during the management, and to confine and isolate the patient from other dogs to prevent the spread of the disease within the community.

Key words: Canine, Histopathology, Indigenous Dog, Transmissible venereal tumour, Nigeria





Bibliomed Article Statistics

20
37
33
16
R
E
A
D
S



19

37

4
D
O
W
N
L
O
A
D
S
04050607
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.